The USA Deep Vein Thrombosis (DVT) Interventional landscape, Procedure and Technology Trends, Brand Perception, Competitive Intelligence and Future Outlook (2019-2022)

September 2022
The USA Deep vein thrombosis (DVT) report is the first-ever syndicated report that covers the market landscape, procedural and technology trends, and competitive intelligence. The report is based on exhaustive secondary research and in-depth primary research conducted with performing physicians in Interventional Radiology and Vascular Surgery departments from academic/university hospitals, community teaching hospitals, non-teaching hospitals, and private practice in the USA.
    The report covers:

  • Deep vein thrombosis interventional procedures: acute, sub-acute, and chronic stages of deep vein thrombosis
  • Interventional devices: venous stents, venous balloons, thrombectomy devices, and inferior vena cava filter
  • Procedure trends: stages of the disease, vein clot location, route of access used for the intervention, and type of interventions
“We typically have to oversize a lot.  So, balloon-expandable stent in the vein is probably not going to be done.  We are going to be looking at a self-expanding stent”

– Vascular surgeon, USA

  • ~54% of DVT procedures are performed for clots formed in the Iliac vein
  • ~76% of venous stenting procedures use venous self-expanding stents
  • 84% of patients are referred to interventionalists in severe stages

  • Insights on reimbursement such as the variance of insurance coverage for DVT procedures across provinces and cities based on the type of insurance scheme are delved upon; one of the key findings is that although nearly 70-80% of DVT interventions are covered under public insurance, few patients opt for private insurances to increase coverage – are some of the unique insights covered only in this study.

    Physician’s brand perception and their rank of medical device companies based on 15 KPIs such as technology, clinical evidence, patient outcome, etc. Moreover, diligent examination of physician’s brand usage and brand satisfaction levels, and the factors such as ease of use of the device, and cost-effectiveness among others affecting brand usage have been covered.

    Future trends such as the introduction of new mechanical thrombectomy devices will shorten procedure durations and reduce out-of-pocket expenditure and healthcare expansion will drive volumes in the future.

    The coverage of competitor activities includes market events such as emerging companies, product approvals, clinical trials, partnerships, etc. Information on ongoing clinical trials by domestic companies like the SaExten IVCF System in Prevention of PE by ShenZhen KYD Biomedical Technology Co., Ltd and new product developments and acquisitions by key players like Boston Scientific, Cook Medical, Philips Healthcare, and Invamed are covered in the report.

What’s in it for you?

  • This report will help deep vein thrombosis (DVT) interventional device companies understand the deep vein thrombosis intervention landscape in the USA, procedural and technology trends, the brand perception, in the USA.
  • The report is a great resource to plan your market strategy to capitalize on upcoming trends and potential disruptors in the DVT interventional devices market.
The deliverable includes a 100+ slide MS PowerPoint report and an MS Excel-based 5-Year market forecast model.
REPORT COST: 5,000 USD
Contact us below for further details regarding the exclusive data and insights in the report or for an exploratory analyst walkthrough of the report.

    Drop Us A Line

    We provide the best insights for your business